It’s essentially a venture capital firm buried in the U.S. government. BARDA is the source of hundreds of millions of dollars in biotech grant funds every year, as it seeks to ensure the U.S. is prepared for a range of health threats, from ZIKA to biological warfare. Audience members will learn about the competitive process for these valuable grants, which are often used by biotech companies as non-dilutive funding that helps drive pipeline development. Also, hear about the unique considerations for working with this government agency: What are the secrets to making a BARDA partnership succeed? Gain insights from notable biotech companies who partner with the agency to combat emerging health threats.
Ability Level: All
Session ID: 21159